Whitebox Advisors’s Northwest Biotherapeutics NWBO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
– Sell
-15,078
Closed -$94K – 374
2015
Q3
$94K Sell
15,078
-145,740
-91% -$1.36M ﹤0.01% 325
2015
Q2
$1.6M Buy
+160,818
New +$1.41M 0.07% 222
2014
Q4
– Sell
-20,000
Closed -$101K – 477
2014
Q3
$101K Buy
+20,000
New +$123K ﹤0.01% 384
2014
Q1
– Sell
-548,367
Closed -$2.07M – 493
2013
Q4
$2.07M Buy
548,367
+266,677
+95% +$1.03M 0.09% 169
2013
Q3
$946K Sell
281,690
-478,725
-63% -$1.67M 0.05% 254
2013
Q2
$2.54M Buy
+760,415
New +$2.76M 0.13% 87

Other funds holding NWBO

Whitebox Advisors's NWBO Position: Q4 2015 in Review

Whitebox Advisors sold out of Northwest Biotherapeutics (NWBO) in Q4 2015, closing a stake of 15,078 shares — an estimated $94K sold.

Whitebox Advisors first reported a position in NWBO in Q2 2013 and held it in 6 quarters. The position peaked at $2.54M in Q2 2013. 80 funds tracked by Wall St. Rank hold NWBO as of Q4 2015.

  • Whitebox Advisors reported no remaining Northwest Biotherapeutics position as of Q4 2015 after selling out during the quarter.
  • Whitebox Advisors sold 15,078 Northwest Biotherapeutics shares in Q4 2015, an estimated $94K.
  • Whitebox Advisors first reported a position in Northwest Biotherapeutics in Q2 2013 and held it in 6 quarters.
  • Whitebox Advisors's Northwest Biotherapeutics position peaked at $2.54M in Q2 2013.
  • 80 funds tracked by Wall St. Rank held Northwest Biotherapeutics as of Q4 2015.

Based on Whitebox Advisors's 13F filing for Q4 2015, filed 10 Feb 2016.